Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma

By Chuah Benjamin   Lim Robert   Boyer Michael   Ong Ai-Bee   Wong Seng-Weng   Kong Hwai-Loong   Millward Michael   Clarke Stephen   Goh Boon-Cher  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 234-238

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 929-935

Science Publishers

Access to resources Recommend Favorite

Cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma

By                        

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 171-180

Spandidos Publications

Access to resources Recommend Favorite

The Impact of Surgery, Radiation, and Systemic Treatment on Outcomes in Patients With Ductal Carcinoma In Situ

By Kane Robert L.   Virnig Beth A.   Shamliyan Tatyana   Wang Shi-Yi   Tuttle Todd M.   Wilt Timothy J.  

Journal of the National Cancer Institute Monographs, Vol. 2010, Iss. 41, 2010-10 ,pp. : 130-133

Oxford University Press

Access to resources Recommend Favorite

Intra-arterial Chemotherapy Followed by Chemo-embolisation in Unresectable Hepatocellular Carcinoma

By Colleoni M.   Liessi G.   Mastrapasqua G.   Nelli P.   Vicario G.   Sgarbossa G.   Pancheri F.   Manente P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 56-60

Elsevier

Access to resources Recommend Favorite